Assignee
ZONHON BIOPHARMA INST INC
CN·9 granted patents·9 pending applications·8 citations·filing 2014–2023
Top patents by PatentIndex Score
18 records- 0177US10537620B2Site-specific polyethylene glycolylated (pegylated) asparaginase, preparation method therefor and use thereofZONHON BIOPHARMA INST INC·Filed 2015·Granted Jan 21, 2020·2 cites·11 claims
- 0271US10752686B2Bispecific antibody binding to human CD26 and human CD3, production method therefor and use thereofZONHON BIOPHARMA INST INC·Filed 2015·Granted Aug 25, 2020·3 cites·8 claims
- 0367US10406235B2Use of multi-arm polyethylene glycol modifier and application of multi-arm polyethylene glycol modifier in L-asparaginasum modificationZONHON BIOPHARMA INST INC·Filed 2014·Granted Sep 10, 2019·2 cites·19 claims
- 0464US10052368B2Pegylated tissue kallikrein, and preparation method therefor and uses thereofZONHON BIOPHARMA INST INC·Filed 2014·Granted Aug 21, 2018·1 cites·6 claims
- 0564US2026027044A1Sublingual tablet and application thereof in desensitization therapy drugZONHON BIOPHARMA INST INC·Filed 2023·Application pending·0 cites
- 0664US2025066432A1Recombinant type i allergen of artemisia vulgaris pollen, and preparation method and use thereofZONHON BIOPHARMA INST INC·Filed 2022·Application pending·0 cites
- 0762US11236137B2Recombinant Dermatophagoides farinae type 2 allergen protein and its preparation method and applicationZONHON BIOPHARMA INST INC·Filed 2019·Granted Feb 1, 2022·0 cites·8 claims
- 0861US2025109176A1Recombinant type i allergen of artemisia annua pollen, and preparation method and use thereofZONHON BIOPHARMA INST INC·Filed 2022·Application pending·0 cites
- 0960US2025122257A1Use of kinin or derivative thereof in treating vci, psci, or csvdZONHON BIOPHARMA INST INC·Filed 2023·Application pending·0 cites
- 1060US2025295792A1Polyethylene glycol-modified form of kinin or derivative thereof and pharmaceutical use thereofZONHON BIOPHARMA INST INC·Filed 2023·Application pending·0 cites
- 1159US2025011747A1Underglycosylated kallikrein i, and polyethylene glycol modifier thereof and pharmaceutical use thereofZONHON BIOPHARMA INST INC·Filed 2022·Application pending·0 cites
- 1258US11103565B2Site-specific polyethylene glycolylated (pegylated) asparaginase, preparation method therefor and use thereofZONHON BIOPHARMA INST INC·Filed 2020·Granted Aug 31, 2021·0 cites·10 claims
- 1358US2025154217A1Method for realizing controlled release and sustained release of activity of bioactive molecules and use for drugsZONHON BIOPHARMA INST INC·Filed 2023·Application pending·0 cites
- 1457US11359191B2Variant recombinant dermatophagoides pteronyssinus type 1 allergen protein and its preparation method and applicationZONHON BIOPHARMA INST INC·Filed 2017·Granted Jun 14, 2022·0 cites·4 claims
- 1557US11319353B2Recombinant Dermatophagoides pteronyssinus type 2 allergen protein and its preparation method and applicationZONHON BIOPHARMA INST INC·Filed 2017·Granted May 3, 2022·0 cites·4 claims
- 1657US2025179208A1Anti-cd26 antibodies and use thereofZONHON BIOPHARMA INST INC·Filed 2022·Application pending·0 cites
- 1756US10975128B2Recombinant Dermatophagoides farinae type 1 allergen protein and its preparation method and applicationZONHON BIOPHARMA INST INC·Filed 2019·Granted Apr 13, 2021·0 cites·4 claims
- 1851US2025154276A1Application of cd45 as biomarker in screening effectiveness and precision of cd26 antibody or derivative thereof in treating tumorsZONHON BIOPHARMA INST INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ZONHON BIOPHARMA INST INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →